MOLECULAR CANCER THERAPEUTICS Journal
Overview
publication venue for
- Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer. 20:2577-2584. 2021
- JQ1 Induces DNA Damage and Apoptosis, and Inhibits Tumor Growth in a Patient-Derived Xenograft Model of Cholangiocarcinoma. 17:107-118. 2018
- Combinations of DNA Methyltransferase and Histone Deacetylase Inhibitors Induce DNA Damage in Small Cell Lung Cancer Cells: Correlation of Resistance with IFN-Stimulated Gene Expression. 9:2309-2321. 2010
- Phase II multicenter trial of belinostat (PXD101) in combination with carboplatin and paclitaxel (BelCaP) for patients (pts) with relapsed ovarian cancer 2007
- Sensitization of DNA damage-induced apoptosis by the proteasome inhibitor PS-341 is p53 dependent and involves target proteins 14-3-3 sigma and survivin. 4:1880-1890. 2005
- Resveratrol-induced apoptotic death in human U251 glioma cells. 4:554-561. 2005
Research
category
- ONCOLOGY Web of Science Category
Identity
International Standard Serial Number (ISSN)
- 1535-7163
Electronic International Standard Serial Number (EISSN)
- 1538-8514
Other
journal abbreviation
- MOL CANCER THER